Chugai Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, founded in 1925 and one of Japan's major drug developers. In 2002 the Swiss drugmaker Roche, already live in this atlas, acquired majority ownership of Chugai in a strategic alliance that let Chugai continue operating with significant independence and its own separate listing on the Tokyo Stock Exchange, rather than being fully absorbed into Roche. Chugai has developed a number of internationally significant medicines under this arrangement, including tocilizumab, marketed as Actemra, an antibody drug originally developed for rheumatoid arthritis that was later used to treat severe complications of COVID-19, and the company remains a leading contributor to Roche's global biologics pipeline.
Facts
Company Type Founded Year Headquarters Company Type
Company Type (category) Connections
In the Other Atlases
Located In
Also in Geography Atlas: where this subject is located.
Source Wikipedia: Chugaitier 2
Sources
1. Wikipedia: Chugai
Infobox, type
Public KK
Intro, sentence 2
The company is headquartered in Tokyo
Operates In: Pharmaceutical Industry, Infobox: industry
Pharmaceutical Industry, Business import, production and development of drugs for medical sales
View the Source2. Wikidata: Chugai Pharmaceutical Co., Ltd.
Wikidata Q750619, class allow-list match (w-wdresolver-0926)View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.